Efficient expression by an alphavirus replicon of a functional ribozyme targeted to human immunodeficiency virus type 1

Journal of Virology

Volumn 71, Issue 12, 1997, Pages 9713-9721

  Smith, Stephen M ^a   Maldarelli, Frank ^a   Jeang, Kuan Teh ^a,b  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b Building 4 ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RIBOZYME;

ARTICLE; CATALYSIS; CYTOMETRY; GENETIC TRANSFECTION; GENOME; HUMAN IMMUNODEFICIENCY VIRUS 1; IN SITU HYBRIDIZATION; LONG TERMINAL REPEAT; PRIORITY JOURNAL; PROMOTER REGION; RNA PROBE; SEMLIKI FOREST ALPHAVIRUS; VIRUS REPLICATION;

EID: 0030840327     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.71.12.9713-9721.1997     Document Type: Article

References (27)

1. Berthold, E., and F. A. Maldarelli. 1996. cis-Acting elements in human immunodeficiency virus type 1 RNAs direct viral transcripts to distinct intranuclear locations. J. Virol. 70:4667-4682.
2. Bredenbeek, P. J., and C. M. Rice. 1992. Animal RNA virus expression systems. Semin. Virol. 3:297-310.
3. Cech, T. R. 1993. The efficiency and versatility of catalytic RNA: implications for an RNA world. Gene 135:33-36.
4. Cotten, M., and M. L. Birnstiel. 1989. Ribozyme mediated destruction of RNA in vivo. EMBO J. 8:3861-3866.
5. Dropulic, B., N. H. Lin, and K. T. Jeang. 1993. A method to increase the cumulative cleavage efficiency of ribozymes: thermal cycling. Nucleic Acids Res. 21:2273-2274.
6. Dropulić, B., N. H. Lin, M. A. Martin, and K.-T. Jeang. 1992. Functional characterization of a U5 ribozyme: intracellular suppression of human immunodeficiency virus type 1 expression. J. Virol. 66:1432-1441.
7. Dropulic, B., S. M. Smith, and K. T. Jeang. 1994. Activation and inactivation of gene expression using RNA sequences. Adv. Pharmacol. 30:247-270.
8. El Kharroubi, A., and M. A. Martin. 1996. cis-Acting sequences located downstream of the human immunodeficiency virus type 1 promoter affect its chromatin structure and transcriptional activity. Mol. Cell. Biol. 16:2958-2966.
9. Frolov, I., T. A. Hoffman, B. M. Pragai, S. A. Dryga, H. V. Huang, S. Schlesinger, and C. M. Rice. 1996. Alphavirus-based expression vectors: strategies and applications. Proc. Natl. Acad. Sci. USA 93:11371-11377.
10. Homann, M., S. Tzortzakaki, K. Rittner, G. Sczakiel, and M. Tabler. 1993. Incorporation of the catalytic domain of a hammerhead ribozyme into antisense RNA enhances its inhibitory effect on the replication of human immunodeficiency virus type 1. Nucleic Acids Res. 21:2809-2814.
11. Israel, M. 1993. Molecular approaches to cancer therapy. Adv. Cancer Res. 61:57-85.
12. Kashani-Sabet, M., T. Funato, V. A. Florenes, O. Fodstad, and K. J. Scanlon. 1994. Suppression of the neoplastic phenotype in vivo by an anti-ras ribozyme. Cancer Res. 54:900-902.
13. Kashani-Sabet, M., T. Funato, T. Tone, L. Jiao, W. Wang, E. Yoshida, B. I. Kashfinn, T. Shitara, A. M. Wu, and J. G. Moreno. 1992. Reversal of the malignant phenotype by an anti-ras ribozyme. Antisense Res. Dev. 2:3-15.
14. Liljestrom, P., and H. Garoff. 1991. A new generation of animal cell expression vectors based on the Semliki Forest virus replicon. Bio/Technology 9:1356-1361.
15. Littman, D. R., Y. Thomas, P. J. Maddon, L. Chess, and R. Axel. 1985. The isolation and sequence of the gene encoding T8: a molecule defining functional classes of T lymphocytes. Cell 40:237-246.
16. Lustig, B. N., N. H. Lin, S. M. Smith, R. L. Jernigan, and K. T. Jeang. 1995. A small modified hammerhead ribozyme and its conformational characteristics determined by mutagenesis and lattice calculation. Nucleic Acids Res. 23:3531-3538.
17. Mebatsion, T., M. J. Schnell, J. H. Cox, S. Finke, and K. K. Conzelmann. 1996. Highly stable expression of a foreign gene from rabies virus vectors. Proc. Natl. Acad. Sci. USA 93:7310-7314.
18. Paulus, W., I. Baur, F. M. Boyce, X. O. Breakefield, and S. A. Reeves. 1996. Self-contained, tetracycline-regulated retroviral vector system for gene delivery to mammalian cells. J. Virol. 70:62-67.
19. Rossi, J. J., D. Elkins, N. Taylor, J. A. Zaia, S. Sullivan, and J. O. Deshler. 1991. Exploring the use of antisense enzymatic RNA molecules (ribozymes) as therapeutic agents. Antisense Res. Dev. 1:285-288.
20. Sarver, N., E. M. Cantin, P. S. Chang, J. A. Zaia, P. A. Ladne, D. A. Stephens, and J. J. Rossi. 1990. Ribozymes as potential anti-HIV-1 therapeutic agents. Science 247:1222-1225.
21. Schlesinger, S. 1993. Alphaviruses - vectors for the expression of heterologous genes. Trends Biotechnol. 11:18-22.
22. Schlesinger, S. 1995. RNA viruses as vectors for the expression of heterologous proteins. Mol. Biotechnol. 3:155-165.
23. Steinecke, P., T. Herget, and P. H. Schreier. 1992. Expression of a chimeric ribozyme gene results in endonucleolytic cleavage of target mRNA and a concomitant reduction of gene expression in vivo. EMBO J. 11:1525-1530.
24. Strauss, J. H., and E. G. Strauss. 1994. The alphaviruses: gene expression, replication, and evolution. Microbiol. Rev. 58:491-562.
25. Wang, S., and B. J. Dolnick. 1993. Quantitative evaluation of intracellular sense: antisense RNA hybrid duplexes. Nucleic Acids Res. 21:4383-4391.
26. Xiong, C., R. Levis, P. Shen, S. Schlesinger, C. M. Rice, and H. V. Huang. 1989. Sindbis virus: an efficient, broad host range vector for gene expression in animal cells. Science 243:1188-1191.
27. Yu, M., J. Ojwang, O. Yamada, A. Hampel, J. Rapapport, D. Looney, and F. Wong-Staal. 1993. A hairpin ribozyme inhibits expression of diverse strains of human immunodeficiency virus type 1. Proc. Natl. Acad. Sci. USA 90: 6340-6344.